Abstract 52P
Background
Non-functioning pituitary adenomas (NFPAs) account for nearly 35% of all pituitary tumours but since no hormonal hypersecretion has been observed, the diagnosis of NFPAs remains difficult. Although the NFPAs are considered benign, in a proportion of patients, tumour recurrence and invasion have been observed. So far, no biomarkers for NFPAs monitoring are available. Differentially expressed microRNAs (miRs) have been shown biomarker potential in many solid tumours. In the present study, miRs expression profiles were analysed in patients with invasive (with or without recurrence) and non-invasive NFPAs.
Methods
MiRs profiles were analysed in 12 patients with non-invasive and 8 patients with invasive NFPAs using miRCURY LNA miRNA PCR® (Qiagen). ROC curve analysis evaluated the diagnostic ability of the selected miRNAs. P<0.05 was assumed for statistically significant and was calculated using un-paired, 2-tailed Student’s t-test.
Results
Four miRs were found differentially expressed related to invasion and recurrence of NFPAs. MiR-106a, miR-17, miR-20 were up-regulated in patients with recurrent invasive NFPAs, with an AUR> 0.9 (95% CI = 0.839-1), while miR-210 was down-regulated in invasive NFPAs compared to patients with non-invasive NFPAs.
Conclusions
The ability to predict tumour invasion and recurrence after the initial surgery will decrease morbidity and mortality rate in patients with NFPAs. The selected profile of miR-106a, miR-17, miR-20 and miR-210 showed biomarker potential and could be used for future miRNA – based targeted therapies.
Legal entity responsible for the study
Medical University Sofia.
Funding
Medical University Sofia, grant number D-117/24.06.2020.
Disclosure
All authors have declared no conflicts of interest.